Birinyi Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,075
| Closed | -$1.48M | – | 59 |
|
|
2024
Q4 | $1.48M | Buy |
+2,075
| New | +$1.48M | 0.41% | 28 |
|
|
2017
Q3 | – | Sell |
-500
| Closed | -$246K | – | 91 |
|
|
2017
Q2 | $246K | Buy |
+500
| New | +$246K | 0.12% | 85 |
|
|
2017
Q1 | – | Sell |
-1,000
| Closed | -$367K | – | 95 |
|
|
2016
Q4 | $367K | Buy |
1,000
+500
| +100% | +$184K | 0.21% | 67 |
|
|
2016
Q3 | $201K | Buy |
+500
| New | +$201K | 0.11% | 85 |
|
|
2016
Q2 | – | Sell |
-700
| Closed | -$252K | – | 81 |
|
|
2016
Q1 | $252K | Sell |
700
-500
| -42% | -$180K | 0.11% | 74 |
|
|
2015
Q4 | $651K | Buy |
1,200
+700
| +140% | +$380K | 0.42% | 54 |
|
|
2015
Q3 | $233K | Buy |
500
+50
| +11% | +$23.3K | 0.1% | 83 |
|
|
2015
Q2 | $230K | Buy |
+450
| New | +$230K | 0.16% | 78 |
|